Mr Geoff Brooke, speaking at Private Equity World Australia 2011

Mr Geoff Brooke,
Co-Founder and Managing Partner
GBS Venture Partners, Australia

Dr Geoff Brooke co-founded GBS in 1996 and has more than 20 years venture capital experience. He was formerly President of Medvest Inc., a US-based early-stage venture capital group he co-founded with Johnson & Johnson. Geoff's experience includes company formation and acquisitions, as well as public listings on both NASDAQ and ASX. He has been a founder, executive and director of private and public companies and has an extensive network of international contacts. Geoff is on the board of GBS portfolio companies Chemgenex Pharmaceuticals, CoDa Therapeutics, Sunshine Heart and Uptake Medical.
Geoff is licensed in clinical medicine by the Medical Board of Victoria, Australia and his post-graduate studies were in anaesthetics/intensive care. He earned his Bachelor of Medicine/Surgery from the University of Melbourne, Australia and a Masters of Business Administration from IMEDE (now IMD) in Lausanne, Switzerland.

Appearing:

Conference Day Two: Tuesday 7 June 2011

13.10

Panel: Thawing venture capital’s nuclear winter: creating a venture capital model that provides consistent returns

What is the role of venture capital in Australia?
Recognising venture capital’s potential for growth despite historical poor performance and identifying areas in need of change
Revising the venture capital model to suit the Australian market and generate reliable returns

Mr Nick Birrell,

Venture Executive,
Innovation Capital, Australia

Dr Michelle Deaker,

Managing Partner,
OneVentures Pty Ltd, Australia

Mr John Dyson,

Investment Principal,
Starfish Ventures, Australia

Mr Geoff Brooke,

Co-Founder and Managing Partner,
GBS Venture Partners, Australia

Mr Ian Johnson,

Managing Director,
Helmsman Capital, Australia

back to programme »

Sponsor Private Equity World Australia 2011 ›